Maastricht, Netherlands · Founded 2016 · Privately Held (backing)
Developer of a tissue engineering technology designed for novel therapeutic options for vascular surgery. CuroTis is based in Maastricht, Netherlands and was founded in 2016. Its last reported valuation was $15.7 million in Jan 2025. It has raised $4.4 million.
Last reported valuation
$15.7M
Oct 2026
Priced at
—
Total raised
$4.4M
Last round
—
Cap table — not yet on record
CuroTis's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CuroTis with a free account
·Watch CuroTis: the Monday email on marks, rounds and moves
